Abstract
BackgroundProgressive Multifocal Leukoencephalopathy (PML) is a rare and often fatal opportunistic infection recently associated with several biologic therapies. However, ascribing risk to individual therapies has been problematic. A previous study...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have